Wells Fargo’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $58.1M | Buy |
483,100
+138,100
| +40% | +$15.9M | 0.01% | 880 |
|
|
2025
Q4 | $36.3M | Sell |
345,000
-410,000
| -54% | -$38.5M | 0.01% | 1120 |
|
|
2025
Q3 | $63.4M | Buy |
755,000
+610,000
| +421% | +$50.2M | 0.01% | 806 |
|
|
2025
Q2 | $11.5M | Buy |
145,000
+86,600
| +148% | +$6.88M | ﹤0.01% | 1801 |
|
|
2025
Q1 | $5.24M | Buy |
+58,400
| New | +$5.45M | ﹤0.01% | 2377 |
|
|
2024
Q4 | – | Sell |
-34,700
| Closed | -$3.94M | – | 7153 |
|
|
2024
Q3 | $3.94M | Buy |
34,700
+21,100
| +155% | +$2.51M | ﹤0.01% | 2541 |
|
|
2024
Q2 | $1.68M | Sell |
13,600
-92,100
| -87% | -$11.9M | ﹤0.01% | 3120 |
|
|
2024
Q1 | $13.9M | Buy |
105,700
+105,500
| +52,750% | +$13M | ﹤0.01% | 1480 |
|
|
2023
Q4 | $21.8K | Hold |
200
| – | – | ﹤0.01% | 5609 |
|
|
2023
Q3 | $20.6K | Hold |
200
| – | – | ﹤0.01% | 5585 |
|
|
2023
Q2 | $23.1K | Sell |
200
-7,500
| -97% | -$852K | ﹤0.01% | 5693 |
|
|
2023
Q1 | $819K | Buy |
7,700
+7,500
| +3,750% | +$810K | ﹤0.01% | 3510 |
|
|
2022
Q4 | $22.2K | Sell |
200
-24,800
| -99% | -$2.53M | ﹤0.01% | 5214 |
|
|
2022
Q3 | $2.15M | Sell |
25,000
-132,200
| -84% | -$11.8M | ﹤0.01% | 2672 |
|
|
2022
Q2 | $14.3M | Buy |
157,200
+42,200
| +37% | +$3.74M | ﹤0.01% | 1332 |
|
|
2022
Q1 | $9.44M | Buy |
+115,000
| New | +$9.07M | ﹤0.01% | 1883 |
|
|
2021
Q2 | – | Sell |
-130,790
| Closed | -$9.62M | – | 7235 |
|
|
2021
Q1 | $9.62M | Buy |
130,790
+98,092
| +300% | +$7.24M | ﹤0.01% | 2229 |
|
|
2020
Q4 | $81K | Sell |
32,698
-8,279
| -20% | -$633K | ﹤0.01% | 5434 |
|
|
2020
Q3 | $14K | Buy |
+40,977
| New | +$3.21M | ﹤0.01% | 5831 |
|
|
2019
Q4 | – | Sell |
-115,070
| Closed | -$35K | – | 6607 |
|
|
2019
Q3 | $35K | Buy |
+115,070
| New | +$9.22M | ﹤0.01% | 5664 |
|
|
2019
Q1 | – | Sell |
-368,162
| Closed | -$120K | – | 6309 |
|
|
2018
Q4 | $120K | Buy |
+368,162
| New | +$26M | ﹤0.01% | 5200 |
|
|
2018
Q3 | – | Sell |
-31,964
| Closed | -$137K | – | 6504 |
|
|
2018
Q2 | $137K | Sell |
31,964
-99,141
| -76% | -$5.59M | ﹤0.01% | 5220 |
|
|
2018
Q1 | $98K | Buy |
131,105
+59,527
| +83% | +$3.21M | ﹤0.01% | 5308 |
|
|
2017
Q4 | $18K | Buy |
+71,578
| New | +$3.97M | ﹤0.01% | 5812 |
|
|
2017
Q3 | – | Sell |
-68,958
| Closed | -$195K | – | 6404 |
|
|
2017
Q2 | $195K | Sell |
68,958
-157,200
| -70% | -$9.57M | ﹤0.01% | 4803 |
|
|
2017
Q1 | $328K | Buy |
+226,158
| New | +$13.7M | ﹤0.01% | 4525 |
|
|
2016
Q4 | – | Sell |
-157,200
| Closed | -$144K | – | 6370 |
|
|
2016
Q3 | $144K | Buy |
+157,200
| New | +$9.19M | ﹤0.01% | 4675 |
|
|
2016
Q1 | – | Sell |
-82,268
| Closed | -$27K | – | 6342 |
|
|
2015
Q4 | $27K | Buy |
82,268
+40,348
| +96% | +$2.03M | ﹤0.01% | 5494 |
|
|
2015
Q3 | $7K | Hold |
41,920
| – | – | ﹤0.01% | 5788 |
|
|
2015
Q2 | $66K | Buy |
+41,920
| New | +$2.35M | ﹤0.01% | 5233 |
|
|
2014
Q2 | – | Sell |
-1,048
| Closed | -$1K | – | 6221 |
|
|
2014
Q1 | $1K | Buy |
+1,048
| New | +$54.3K | ﹤0.01% | 5773 |
|
|
2013
Q4 | – | Sell |
-131,000
| Closed | -$15K | – | 5851 |
|
|
2013
Q3 | $15K | Buy |
+131,000
| New | +$5.98M | ﹤0.01% | 5033 |
|
Other funds holding MRK
VCM
VPM
Wells Fargo's MRK Position: Q1 2026 in Review
Wells Fargo increased its Merck (MRK) stake by 3.6% in Q1 2026, buying an estimated $46M and bringing the position to 11,446,845 shares worth $1.38B. The position accounts for 0.26% of the portfolio, ranked #83.
Wells Fargo first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.16B in Q1 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Wells Fargo held 11,446,845 shares of Merck worth $1.38B as of Q1 2026.
- Wells Fargo bought 398,634 Merck shares in Q1 2026, an estimated $46M.
- Merck made up 0.26% of Wells Fargo's portfolio in Q1 2026, its #83 holding.
- Wells Fargo first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
- Wells Fargo's Merck position peaked at $2.16B in Q1 2024.
- 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.